Basit öğe kaydını göster

dc.contributor.authorYardan T.
dc.contributor.authorBaydin A.
dc.contributor.authorDemircan S.
dc.contributor.authorAygün D.
dc.contributor.authorDoğanay Z.
dc.date.accessioned2020-06-21T09:23:54Z
dc.date.available2020-06-21T09:23:54Z
dc.date.issued2004
dc.identifier.issn1300-2996
dc.identifier.urihttps://hdl.handle.net/20.500.12712/3693
dc.description.abstractB type natriuretic peptide (BNP) is a cardiac neurohormone secreted mainly from ventricles in response to volume expansion and pressure overload and it has diuretic, natriuertic and vasodilatator effects. Increased BNP level is important in determining heart failure in a patient presenting with respiratory failure. Additionally, it has been reported that BNP is useful in the diagnosis and classification of cardiac failure, determining the prognosis of cardiac failure, and assessing the efficiency of treatment in cardiac failure. Recently, it has been reported that nesiritid, a recombinant BNP is useful to use in addition to other therapy methods in severe cardiac failure. In this paper, we discuss the role in the diagnosis and prognosis of cardiac failure, and assessing the efficiency of treatment in cardiac failure.en_US
dc.language.isoturen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBNPen_US
dc.subjectChronic heart failureen_US
dc.subjectNesiritiden_US
dc.titleThe role of B-type natiuratic peptide in heart failureen_US
dc.title.alternativeB-tipi natriüretik peptidin kalp yetersizliğindeki yerien_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume21en_US
dc.identifier.issue4en_US
dc.identifier.startpage188en_US
dc.identifier.endpage194en_US
dc.relation.journalOndokuz Mayis Universitesi Tip Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster